Iberia Foods Company of New York, Inc
Letter data
- Company
- Iberia Foods Company of New York, Inc
- Recipient
- Eric S. Miller | CEO | Iberia Foods Company of New York, Inc | Iberia Foods Company of New York, Inc | 1900 Linden Boulevard | Brooklyn | , | NY | 11207-6806 | United States
- Issue date
- 2019-03-13
- Posted date
- Not available
- FDA office
- Center for Food Safety and Applied Nutrition
- Subject
- Not available
- Product
- Not available
- CMS ID
- 435841
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Iberia Foods Company of New York, Inc
MARCS-CMS 435841 —
March 13, 2019
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
United Parcel Service
Recipient:
Recipient Name
Eric S. Miller
Recipient Title
CEO
Iberia Foods Company of New York, Inc
Iberia Foods Company of New York, Inc
1900 Linden Boulevard
Brooklyn
,
NY
11207-6806
United States
Issuing Office:
Center for Food Safety and Applied Nutrition
158-15 Liberty Avenue
Jamaica
,
NY
11433
United States
Dear Mr. Miller:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NYK-2014-53, issued on July 31, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
CDR Catherine Beer
Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1
Content current as of:
03/19/2019